Italy | Symmetron

Economic evaluation of tocilizumab combination in the treatment of moderate to severe rheumatoid arthritis in Italy

by Symmetron | Jan 21, 2019

Rheumatoid arthritis Economic evaluation of tocilizumab combination in the treatment of moderate to severe rheumatoid arthritis in Italy Journal of Medical Economics. 2012;15(3):576-85 Authors Diamantopoulos A, Benucci M, Capri S, Berger W, Wintfeld N, Giuliani G,...

An economic evaluation of cetuximab combined with radiotherapy for patients with locally advanced head and neck cancer in Belgium, France, Italy, Switzerland, and the United Kingdom

by Symmetron | Jan 21, 2019

Cancer An economic evaluation of cetuximab combined with radiotherapy for patients with locally advanced head and neck cancer in Belgium, France, Italy, Switzerland, and the United Kingdom Value in Health. 2008;11(5):791-9 Authors Brown B, Diamantopoulos A, Bernier J,...

Cost-effectiveness impact of rivaroxaban versus new and existing prophylaxis for the prevention of venous thromboembolism after total hip or knee replacement surgery in France, Italy and Spain

by Symmetron | Jan 17, 2019

Venous Thromboembolism Cost-effectiveness impact of rivaroxaban versus new and existing prophylaxis for the prevention of venous thromboembolism after total hip or knee replacement surgery in France, Italy and Spain Thrombosis and Haemostasis. 2013 Nov;110(5):987-94...

Economic evaluation of tocilizumab combination in the treatment of moderate to severe rheumatoid arthritis in Italy

An economic evaluation of cetuximab combined with radiotherapy for patients with locally advanced head and neck cancer in Belgium, France, Italy, Switzerland, and the United Kingdom

Cost-effectiveness impact of rivaroxaban versus new and existing prophylaxis for the prevention of venous thromboembolism after total hip or knee replacement surgery in France, Italy and Spain

Recent Comments

Archives

Categories

Meta